Trichloroethylene

Trichloroethylene

SCHEMBL608049

Cl/C=C(/Cl)CCl.ClC=C(Cl)Cl

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.53
CASP1 P29466 1/20 0.53
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trichloroethylene SCHEMBL608051 1.00 TSHR (0.53) TSHRCASP1ALDH1A1
SCHEMBL185997 0.93
SCHEMBL1756189 0.93
SCHEMBL1078539 0.93
Trichloroethylene SCHEMBL7555926 0.78
Trichloroethylene SCHEMBL8580835 0.78
Trichloroethylene SCHEMBL5754 0.73
Trichloroethylene SCHEMBL242488 0.73
Trichloroethylene SCHEMBL1331201 0.73
Trichloroethylene SCHEMBL5523424 0.73 TSHR (1.00) TSHRCASP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925738-B1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF GFBIOCHEMICALS LTD (MT) 2018-01-10 EP disclosed
US-9458414-B2 Cleaning, surfactant, and personal care compositions GFBIOCHEMICALS LIMITED (MT) 2016-10-04 US disclosed
US-9156809-B2 Carboxy ester ketals, methods of manufacture, and uses thereof SEGETIS, INC. (US) 2015-10-13 US disclosed
EP-2925738-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF Segetis, Inc. (US) 2015-10-07 EP disclosed
US-20150252302-A1 CLEANING, SURFACTANT, AND PERSONAL CARE COMPOSITIONS SEGETIS, INC. (US) 2015-09-10 US disclosed
US-8828917-B2 Carboxy ester ketal removal compositions, methods of manufacture, and uses thereof SEGETIS, INC. (US) 2014-09-09 US disclosed
WO-2014085609-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2014-06-05 WO disclosed
US-20140147395-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2014-05-29 US disclosed
WO-2014047428-A1 CLEANING, SURFACTANT, AND PERSONAL CARE COMPOSITIONS SEGETIS, INC. (US) 2014-03-27 WO disclosed
EP-2603836-A2 CARBOXY ESTER KETAL REMOVAL COMPOSITIONS, METHODS OF MANUFACTURE, AND USES THEREOF Segetis, Inc. (US) 2013-06-19 EP disclosed
WO-2012021824-A2 CARBOXY ESTER KETAL REMOVAL COMPOSITIONS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2012-02-16 WO disclosed
US-20120040880-A1 CARBOXY ESTER KETAL REMOVAL COMPOSITIONS, METHODS OF MANUFACTURE, AND USES THEREOF SEGETIS, INC. (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140147395-A1 CARBOXY ESTER KETALS, METHODS OF MANUFACTURE, AND USES THEREOF C9, C5, C1S TSHR 3990/4885CASP1 809/4885ALDH1A1 769/4885
US-20120040880-A1 CARBOXY ESTER KETAL REMOVAL COMPOSITIONS, METHODS OF MANUFACTURE, AND USES THEREOF CRAT, KDM6A, KAT6A TSHR 3827/4885CASP1 801/4885ALDH1A1 43/4885
US-20150252302-A1 CLEANING, SURFACTANT, AND PERSONAL CARE COMPOSITIONS ADH1C, C5, KAT7 TSHR 1209/4885CASP1 654/4885ALDH1A1 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.